Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

XXilio Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
X

Xilio Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $18.69M. Net result −$6.37M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $18.69M. Running result $18.69M. Revenue: $18.69M.
  • Cost of revenue: $0. Running result $18.69M.
  • Gross profit: $18.69M. Running result $18.69M.
  • Research and development: −$14.56M. Running result $4.13M.
  • General and administrative: −$7.62M. Running result −$3.49M.
  • Operating income: −$3.49M. Running result −$3.49M.
  • Other expense: −$2.88M. Running result −$6.37M.
  • Pre-tax loss: −$6.37M. Running result −$6.37M.
  • Income tax benefit: $0. Running result −$6.37M.
  • Net loss: −$6.37M. Running result −$6.37M.